Role of active and latent transforming growth factor β in bone formation

At first reading the statement “TGFβ stimulates bone formation but inhibits mineralization” may appear to be an oxymoron. However, the bone formation process can take weeks to months to complete, and the unique properties of TGFβ allow this factor to be stored in bone matrix in a latent form, ready to be activated and inactivated at key, pivotal stages in this long process. TGFβ may act to trigger the cascade of events that ultimately leads to new bone formation. However, once this process is initiated, TGFβ must then be inactivated or removed because if present in the later stages of bone formation, mineralization will be inhibited. The unique properties of TGFβ and its role in bone remodeling are the subject of this review. © 1994 Wiley‐Liss, Inc.

[1]  Sporn,et al.  Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. , 1988, The Journal of biological chemistry.

[2]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[3]  G. Rodan,et al.  Type-β transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells , 1986 .

[4]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[5]  M. Noda.  Transcriptional regulation of osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells. , 1989, Endocrinology.

[6]  F. Ruscetti,et al.  γ‐Interferon‐Induced Activation of Latent Transforming Growth Factor‐β by Human Monocytes , 1990 .

[7]  N. Ling,et al.  Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. , 1980, The Journal of biological chemistry.

[8]  H. Moses,et al.  Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.

[9]  L. Bonewald,et al.  Latent Forms of Transforming Growth Factor-β (TGFβ) Derived from Bone Cultures: Identification of a Naturally Occurring 100-kDa Complex with Similarity to Recombinant Latent TGFβ , 1991 .

[10]  M. Oursler.  Osteoclast synthesis and secretion and activation of latent transforming growth factor β , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[12]  L. Bonewald,et al.  Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long‐term cultures of fetal rat calvarial osteoblasts , 1994 .

[13]  S. Reed,et al.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. , 1992, Science.

[14]  G. Stein,et al.  TGFβ alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype , 1994, Journal of cellular physiology.

[15]  M. Iwamoto,et al.  Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: regulation by transforming growth factor beta and serum factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Russell,et al.  Transforming growth factor β increases ecto‐nucleoside triphosphate pyrophosphatase activity of human bone‐derived cells , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  D. Rowley,et al.  Glucocorticoid regulation of transforming growth factor-beta activation in urogenital sinus mesenchymal cells. , 1992, Endocrinology.

[18]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[19]  L. Lanyon,et al.  Early strain‐related changes in cultured embryonic chick tibiotarsi parallel those associated with adaptive modeling in vivo , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  K. Mann,et al.  Expression of human bone-related proteins in the hematopoietic microenvironment. , 1990, The Journal of clinical investigation.

[21]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Ono,et al.  Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. , 1993, Endocrinology.

[23]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[24]  K. Yamaguchi,et al.  Molecular cloning of the large subunit of transforming growth factor type beta masking protein and expression of the mRNA in various rat tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Gross,et al.  Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. , 1993, DNA and cell biology.

[26]  J. Aubin,et al.  Characterization of the 1,25-(OH)2D3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells. , 1993, Endocrinology.

[27]  J. Aubin,et al.  Effects of transforming growth factor β and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria cells , 1989 .

[28]  G. Stein,et al.  Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein-DNA interactions at promoter regulatory elements. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  David W. Burt,et al.  Evolutionary Origins of the Transforming Growth Factor-β Gene Family , 1992 .

[30]  S. Sriram,et al.  Experimental allergic encephalomyelitis: Neutralizing antibody to TGFβ1 enhances the clinical severity of the disease , 1993, Journal of Neuroimmunology.

[31]  E. Allan,et al.  Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells , 1993, Journal of cellular physiology.

[32]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Bonewald,et al.  Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. , 1994, The Journal of biological chemistry.

[34]  K. Miyazono,et al.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. , 1988, The Journal of biological chemistry.

[35]  Sandra R. Smith,et al.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Bonewald,et al.  Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. , 1989, Biochemical and biophysical research communications.

[37]  D. Rifkin,et al.  Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity , 1992, The Journal of cell biology.

[38]  Theresa L. Chen,et al.  Recombinant human transforming growth factor β1 modulates bone remodeling in a mineralizing bone organ culture , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  G. Mundy,et al.  In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice , 1990 .

[40]  K. Miyazono,et al.  TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences , 1990, Cell.

[41]  J. Massagué,et al.  Betaglycan presents ligand to the TGFβ signaling receptor , 1993, Cell.

[42]  E. Chen,et al.  Complementary DNA Cloning of the Murine Transforming Growth Factor-β3 (TGFβ3) Precursor and the Comparative Expression of TGFβ3 and TGFβ1 Messenger RNA in Murine Embryos and Adult Tissues , 1989 .

[43]  D. Rosen,et al.  Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Derynck,et al.  Human Transforming Growth Factor- β3: Recombinant Expression, Purification, and Biological Activities in Comparison with Transforming Growth Factors-β 1 and -β2 , 1989 .

[45]  E. Canalis,et al.  Transforming growth factor-beta and remodeling of bone. , 1991, The Journal of bone and joint surgery. American volume.

[46]  S. Wysocki,et al.  Recombinant human bone morphogenetic protein‐2 enhances expression of interleukin‐6 and transforming growth factor‐β1 genes in normal human osteoblast‐like cells , 1994 .

[47]  J. Wergedal,et al.  Differentiation of normal human bone cells by transforming growth factor-beta and 1,25(OH)2 vitamin D3. , 1992, Metabolism: clinical and experimental.

[48]  A. Brunner,et al.  Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells , 1987, Molecular and cellular biology.

[49]  R. Ziegler,et al.  Chemotactic response of osteoblastlike cells to transforming growth factorβ , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  M. Kuwano,et al.  The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells , 1993, The Journal of cell biology.

[51]  J. Murphy-Ullrich,et al.  Thrombospondin causes activation of latent transforming growth factor- beta secreted by endothelial cells by a novel mechanism [published erratum appears in J Cell Biol 1993 Sep;122(5):following 1143] , 1993, The Journal of cell biology.

[52]  E. Amento,et al.  Rapid publication TGF‐β1 induces bone closure of skull defects , 1991 .

[53]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.